ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 93 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $303,527 | +112735.3% | 91,700 | +11.4% | 0.00% | 0.0% |
Q1 2024 | $269 | -12.4% | 82,300 | -5.9% | 0.00% | 0.0% |
Q4 2023 | $307 | +95.5% | 87,500 | +270.8% | 0.00% | 0.0% |
Q3 2023 | $157 | -20.7% | 23,600 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $198 | -99.7% | 23,600 | -20.5% | 0.00% | – |
Q1 2020 | $73,000 | -57.6% | 29,700 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $172,000 | -44.9% | 29,700 | -50.0% | 0.00% | 0.0% |
Q3 2019 | $312,000 | -27.6% | 59,400 | -17.4% | 0.00% | -50.0% |
Q2 2019 | $431,000 | -28.6% | 71,900 | +7.5% | 0.00% | -33.3% |
Q1 2019 | $604,000 | +87.6% | 66,900 | +72.4% | 0.00% | +50.0% |
Q4 2018 | $322,000 | +403.1% | 38,800 | +725.5% | 0.00% | – |
Q3 2018 | $64,000 | +73.0% | 4,700 | 0.0% | 0.00% | – |
Q2 2018 | $37,000 | – | 4,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |